[1] Vaca L.Point-of-care diagnostic tools to detect circulating microRNAS as biomarkers of disease[J].Sensors(Basel),2014,14(5):9117-9131.
[2] Wu H,Kong L,Zhou S,et al.The role of microRNAs in diabetic nephropathy[J].J Diabetes Res,2014,2014:920134.
[3] Castro NE,Kato M,Park JT,et al.Transforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells[J].J Biol Chem,2014,289(42):29001-29013.
[4] Long J,Wang Y,Wang W,et al.MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1,and its in vivo knockdown prevents progression of diabetic nephropathy[J].J Biol Chem,2011,286(13):11837-11848.
[5] Kato M,Zhang J,Wang M,et al.MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors[J].Proc Natl Acad Sci U S A,2007,104(9):3432-3437.
[6] Wang Q,Wang Y,Minto AW,et al.MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy[J].FASEB J,2008,22(12):4126-4135.
[7] Zhao B,Li H,Liu J,et al.MicroRNA-23b targets ras GTPase-activating protein SH3 domain-binding protein 2 to alleviate fibrosis and albuminuria in diabetic nephropathy[J].J Am Chem Soc,2016,27(9):2597-2608.
[8] Koga K,Yokoi H,Mori K, et al.MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy[J].Diabetologia,2015, 58(9):2169-2180.
[9] Wang J,Duan L,Guo T,et al.Downregulation of miRNA-30c promotes renal fibrosis by target CTGF in diabetic nephropathy[J].J Diabetes Complicat,2016,30(3):406-414.
[10] Etikala DM,Liu R,Wang L.FOXP3-micro RNA-146-NF-kappa B as oncotarget[J].Oncoscience,2015,2(10):839-840.
[11] Wang X,Shen E,Wang Y,et al.MiR-196a regulates high glucose-induced mesangial cell hypertrophy by targeting p27kip1[J].J Lab Autom,2015,20(4):491-499.
[12] Zhang Z,Luo X,Ding S,et al.MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy[J].FEBS Lett,2012,586(1):20-26.
[13] Baker MA,Davis SJ,Liu P,et al.Tissue-specific microRNA expression patterns in four types of kidney disease[J].J Am Soc Nephrol,2017, 28(10):2985-2992.
[14] 潘竞锵,刘广南.茵陈蒿对小鼠血糖、血脂的影响[J].中药材,1998,21 (8):408-411.
[15] 潘竞锵,韩超,刘惠纯,等.茵陈蒿汤对正常和多种糖尿病模型动物血糖的影响[J].中药材,2001,24(2):128-131.
[16] 栾智杰.茵陈蒿汤对腺嘌呤肾衰大鼠CTGF和TGF-β1表达的影响[D].哈尔滨:黑龙江省中医研究院,2011.
[17] 耿嘉男.茵陈提取物对糖尿病肾病防治作用的研究[D].长春:吉林大学,2015.
[18] 彭睿,查何,周吉,等.糖尿病肾病循环microRNA差异表达谱的分析[J].西南大学学报:自然科学版,2014,36(11):75-82.
[19] 张政,罗勇军,彭惠民,等.早期糖尿病肾病相关微小RNA在小鼠肾脏的表达变化[J].第三军医大学学报,2010,32(13):1383-1386.
[20] 杨雪唯,梁小弟,努尔斯曼古丽·奥斯曼,等.MicroRNA及其靶基因在糖尿病肾病小鼠肾脏的表达[J].科技导报,2017,35(4):84-89.
[21] Campion CG,Sanchez-Ferras O,Batchu SN.Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy[J].Can J Kidney Health Dis,2017,22(4):205435811770537.
[22] 郝传明,张敏.糖尿病肾病的防治策略-三级预防一体化治疗[J].中国实用内科杂志,2017, 37 (3):195-198.
[23] 孙赟.复方积雪草合剂治疗早期糖尿病肾病临床疗效观察[J].中国实用内科杂志,2017, 37(5):467-468. |